LAMP

The researchers built a combination nucleic acid-antibody test for the disease using an approach they said could be generally useful for rapid test development.

Japanese researchers developing the method highlighted its ability to accurately and rapidly diagnose different strains of malaria in resource-limited endemic regions. 

A new assay uses digital loop-mediated isothermal amplification (dLAMP) to perform phenotypic antibacterial susceptibility testing in 30 minutes.

The test leverages loop mediated isothermal amplification technology and enables the rapid detection of Neisseria meningitidis directly from cerebrospinal fluid samples.

Researches are advancing it mainly for use in mosquito surveillance efforts, but also collected data supporting clinical testing of human samples.

P. falciparum by Dr. Osaro Erhabor, Wikimedia Commons

The studies provide further support for Meridian's Illumigene Malaria as a tool for routine screening of travelers in non-endemic areas of the world.

The device, which will be tested in collaboration with a Panamanian research institute, will run 40-minute tests without the need for electricity.

The company's net earnings rose, and it reaffirmed its guidance of $195 million to $200 million in revenues for full year 2016.

The LAMP-based test is faster and more sensitive, allowing faster treatment and more accurate diagnosis for malaria patients.

HiberGene will use the funding to develop and commercialize tests for Group B Streptococcus, Clostridium difficile, and norovirus.

Pages

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.